ArticleJAMA dermatology2014

Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgaris.

Christoph T Ellebrecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.